Oral physostigmine and impaired memory in adults with brain injury

References

• Brooks D. Memory and head injury. Journal of Nervous and Mental Disease 1972; 155: 350–355
   PubMed Web of Science ®Google Scholar
• Brooks D. Recognition memory and head injury. Journal of Neurology, Neurosurgery and Psychiatry 1974; 37: 794–801
   PubMed Web of Science ®Google Scholar
• Brooks D. N. Long and short term memory in head injured patients. Cortex 1975; 11: 328–340
   Google Scholar
• Hannay H. J., Levin H. S., Grossman R. G. Impaired recognition memory after head injury. Cortex 1979; 15: 269–283
   PubMed Web of Science ®Google Scholar
• Levin H. S., Benton A. L., Grossman R. G. Neurobehavioral Consequences of Closed Head Injury. Oxford University Press, New York 1982
   Google Scholar
• Reusch J. Intellectual impairment in head injuries. American Journal of Psychiatry 1944; 100: 480–496
   Google Scholar
• Schacter D. L., Crovitz H. F. Memory function after closed head injury.: a review of the quantitative. Cortex 1977; 13: 150–176
   PubMed Web of Science ®Google Scholar
• Bartus R. T. Physostigminc and recent memory.: effects in young and aged nonhuman primates. Science 1979; 206: 1087–1089
   PubMed Web of Science ®Google Scholar
• Deutsch J. A. The cholinergic synapse and the site of memory. Science 1971; 174: 788–794
   PubMed Web of Science ®Google Scholar
• Drachman D. A., Sahak1an B. J. Effects of cholinergic agents on human learning and memory. Nutrition and the Brain, A Barbcau, J. H. Growdon, R. J. Wurtman. Raven Press, New York 1979; vol. 5: 351–366
   Google Scholar
• Caltagirone C., Gainotti G., Masullo C. Oral administration of chronic physostigminc docs not improve cognitive or amnesic performances in Alzheimer's presenile dementia. International Journal of Neuroscience 1982; 16: 247–249
   PubMed Web of Science ®Google Scholar
• Caltagirone C., Albanese A., Gainotti G., et al. Acute administration of individual optimal dose of physostigminc fails to improve amnesic performances in Alzheimer's presenile dementia. International Journal of Neuroscience 1983; 18: 143–148
   PubMed Web of Science ®Google Scholar
• Mohs R. C., Rosen W. G., Davis K. L. Defining treatment efficacy in patients with Alzheimer's Disease. Alzheimer's Disease.: A Report of Progress in Research, S. Corkin, K. L. Davis, J. H. Growdon, et al. Raven Press, New York 1982; 351–356
   Google Scholar
• Peters B. H., Levin H. S. Chronic oral physostigminc and lecithin administration in memory disorders of aging. Alzheimer's Disease.: A Report of Progress in Research, S. Corkin, K. L. Davis, J. H. Growdon, et al. Raven Press, New York 1982; 421–426
   Google Scholar
• Smith C. M., Semple S. A., Swash M. Effects of physostigmine on response in memory tests in patients with Alzheimer's disease. Alzheimer's Disease.: A Report of Progress in Research, S. Corkin, K. L. Davis, J. H. Growdon. Raven Press, New York 1982; 405–411, Physostigmine and memory 587 etal.
   Google Scholar
• Sullivan E. V., Shedlock K. J., Corkin S., . Physostigmine and lecithin in Alzheimer's disease. Alzheimer's Disease.: A Report of Progress in Research, S. Corkin, K. L. Davis, J. H. Growdon, et al. Raven Press, New York 1982; 361–367
   Google Scholar
• Thal L. J., Fuld P. A. Memory enhancement with oral physostigmine in Alzheimer's disease. Journal of Medicine 1983; 308: 720–721
   Google Scholar
• Thal L. J., Fuld P. A., Masur D. M., et al. Oral physostigmine and legithin improve memory in Alzheimer's disease. Annals of Neurology 1983; 13: 491–496
   PubMed Web of Science ®Google Scholar
• McLean A., Jr, Stanton K. M., Cardenas D. D., et al. Memory training combined with the use of oral physostigmine. Brain Injury 1987; 1(2)145–159
   PubMedGoogle Scholar
• Sunderland T., Jariot P. N., Cohen R. M., et al. Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age-matched controls. Archives of General Psychiatry 1987; 44: 418–426
   PubMed Web of Science ®Google Scholar
• Ridley R. M., Samson N. A., Baker H. F., et al. Visuospatial learning impaired following lesion of the cholinergic projection to the hippocampus. Brain Research 1988; 456: 71–87
   PubMed Web of Science ®Google Scholar
• Wechsler D. A standardized memory scale for clinical use. Journal of Psychology 1945; 19: 87–95
   Web of Science ®Google Scholar
• Buschke H. Selective reminding for analysis of memory and learning. Journal of Verbal Learning and Verbal Behavior 1973; 12: 543–550
   Google Scholar
• Buschke H., Fuld P. Evaluating storage, retention and retrieval in disordered memory and learning. Journal of Verbal Learning and Verbal Behavior 1974; 24: 1019–1025
   Google Scholar
• Clinical Neuropsychology.: Current Status and Applications, R. Reitan, M. And, I. A. Davison. Winston & Sons, Washington, DC 1974
   Google Scholar
• Wechsler D. Wechsler Adult Intelligence Scale Revised. Psychological Corporation, San Antonio, Texas 1981
   Google Scholar
• Sunderland A., Harris J. E., Baddelen A. D. Do laboratory tests predict everyday memory? A neuropsychological study. Journal of Verbal Learning and Behavior 1983; 22: 341–357
   Google Scholar
• Butler P. F., Ritvo M. Physostigmine as a peristaltic stimulant. Journal of the American Medical Association 1932; 99: 1329–1332
   Google Scholar
• Martin H. E., Weiss S. The use of physostigmine in abdominal distention. Journal of the American Medical Association 1925; 84: 1407–1408
   Google Scholar
• Ritvo M., Weiss S. Physostigmine as an aid in gastrointestinal roentgen-ray diagnosis. American Journal of Radiation Therapy 1927; 18: 301–314
   Google Scholar
• Sharpless N. S., Thal L. J. Plasma physostigmine concentrations after oral administration. Lancet 1985; i: 1397–1398
   Google Scholar
• Davis K. L., Mohs R. C., Tinklenberg J. R., et al. Physostigmine improvement of long-term memory process in normal subjects. Science 1978; 201: 272–274
   PubMed Web of Science ®Google Scholar
• Davis K. L., Yamamura H. I. Cholinergic underactivity in human memory disorders. Life Sciences 1978; 23: 1729–1734
   PubMed Web of Science ®Google Scholar
• Mohs R., Davis K., Datley C. Cholinergic drug effects on memory and cognition in humans. Aging in the 1980s, L. W. Poon. American Psychological Association, Washington, DC 1980; 181–190
   Google Scholar
• Zeisel S., Reinstein D., Corkin S., et al. Cholinergic neurones decrease memory. Nature 1981; 293: 187–188
   PubMed Web of Science ®Google Scholar
• Coye M. J., Lowe J. A., Mapdy K. T. Biological monitoring of agricultural workers exposed to pesticides. I. cholinesterase activity determinations. Journal of Occupational Medicine 1986; 28: 519–527
   Google Scholar
• Parrot A. C. Transdermal scopolamine.: effects of single and repeated patches upon psychological task performance. Neuropsychology 1987; 17: 53–59
   Google Scholar
• Grober E., Leipzig R. M., Lipton R. B., et al. Docs scopolamine directly impair memory?. Journal of Cognitive Neuroscience 1989; 1(4)327–335
   PubMedGoogle Scholar
• Levin E. D., McGurk S. T., Rose J. E., et al. Cholinergic-dopaminergic interactions in cognitive performance. Behavioral and Neural Biology 1990; 54: 271–299
   PubMedGoogle Scholar
• Caine E. D., Weingartner H., Ludlow C. L., et al. Qualitative analysis of scopolaminc-induced amnesia. Psychopharmacology 1981; 74: 74–80
   PubMed Web of Science ®Google Scholar
• Pieteu-Kark R. A., Blass J. P., Spence M. A. Physostigmine in familial ataxias. Neurology 1977; 27: 70–72
   PubMed Web of Science ®Google Scholar